Newspoint on MSN
Fastest Pakistani drama to cross 1 billion views on YouTube 2026
Islamabad: Meri Zindagi Hai Tu, starring Hania Aamir and Bilal Abbas Khan, continues to dominate conversations as one of the most talked-about Pakistani dramas currently on air. The drama features ...
In the sienna-colored curves of Pakistan’s Hindu Kush mountains, one of the most rugged and lawless regions in the world, a cavernous, grooved crater gouged out from a hillside shines in the winter ...
India Today's analysis identified at least 15 YouTube channels actively streaming Pakistani drama content and monetising it, all of which remain accessible in India. In addition, five Pakistan-based ...
Washington wants critical minerals from Pakistan, but insurgents armed with abandoned US weapons are complicating the race ...
ISLAMABAD — Pakistani authorities ordered inquiries Friday into a video showing the public flogging of a screaming teenage girl in a northwestern valley where officials have yielded to Taliban demands ...
Add Yahoo as a preferred source to see more of our stories on Google. A Fair Lawn nursing student's murder went unsolved for 60 years. Now, police believe they've identified her killer. CBS News New ...
From a timely immigration doc to the greatest party of Black luminaries ever held, Sundance 2026 closes out its stint in Utah ...
Yoon Bom (Lee Joo-bin) is a high school teacher who leaves her busy life in Seoul after a painful heartbreak. She moves to a quiet, small town called Sinsu for a fresh start. At first, she is cold and ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
After the release of Apple Creator Studio, users will lose access to both programs' 90-day trial periods, though they’ll still get 30 days if they sign on to the subscription service. Apple's new ...
Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results